Join us on Wednesday, October 13, 2010 for a preview of key findings from Axendia’s upcoming research report. The report reveals the need for a new paradigm for Global Supply Chains in Life Sciences. Globalization and Outsourcing dynamics are driving the Life Science ecosystem to seek innovative approaches, which improve product safety for enhanced clinical outcomes while at the same time reducing costs and risks, all while ensuring compliance with all applicable regulatory requirements.
To attain the sustained benefits of Global Supply Chains, Brand Owners must implement strategies, which capitalize on the benefits of globalization and outsourcing while proactively reducing and controlling risks. This calls for changing the business, technology and regulatory models traditionally used in the industry.
Join Axendia’s Daniel R. Matlis and Camstar’s Karim Lokas on Wednesday, October 13, 2010 for this webcast and get a preview of key findings from Axendia’s upcoming research report.